Cargando…
Investigating expressed RNA variants that are related to disease severity in SARS-CoV-2-infected patients with mild-to-severe disease
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to be a significant public health challenge globally. SARS-CoV-2 is a novel virus, and the understanding of what constitutes expressed RNAseq variants in healthy, convalescent, severe, moderate, and those admitted to...
Autores principales: | Okendo, Javan, Okanda, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047483/ https://www.ncbi.nlm.nih.gov/pubmed/37521845 http://dx.doi.org/10.1186/s43042-022-00299-5 |
Ejemplares similares
-
Characterization of the expressed RNA variants from young patients with critical and non-critical SARS-CoV-2 infection
por: Okendo, Javan
Publicado: (2022) -
SARS-CoV-2-positive patients display considerable differences in proteome diversity in urine, nasopharyngeal, gargle solution and bronchoalveolar lavage fluid samples
por: Okendo, Javan, et al.
Publicado: (2022) -
SARS-CoV-2 variants and considerations of inferring causality on disease severity
por: Cevik, Muge, et al.
Publicado: (2021) -
The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern
por: Lin, Lixin, et al.
Publicado: (2021) -
Durable SARS-CoV-2 B cell immunity after mild or severe disease
por: Ogega, Clinton O., et al.
Publicado: (2020)